BRAF Mutations and their Implications in Molecular Targeting Therapies for Gastrointestinal Cancers

Shouji Shimoyama^*

Gastrointestinal Unit, Settlement Clinic, 4-20-7, Towa, Adachi-ku, Tokyo, 120-0003, Japan